Immunome IMNM
NASDAQ IMNM
$20.89 -0.62 (-2.88%)
As of: Oct 1, 2026 · 3:59 PM EDT

Immunome (IMNM) Other Operating Expenses (2019 - 2025)

Updated

Immunome (IMNM) posted Other Operating Expenses of $10 million for Q4 2025, down 63.5% from $27.37 million a year earlier.

Analysis

Immunome (IMNM) Other Operating Expenses (2019 - 2025) Analysis & Trends

Since Q3 2019, Immunome has reported Other Operating Expenses for 9 quarters.

  • Annual Other Operating Expenses shows a five-year compound annual growth rate of 12.4% (FY2020 to FY2025).
  • In prior years, Immunome's Other Operating Expenses was $152.34 million in FY2024 (+88.5%) and $80.8 million in FY2023.
  • The Q4 2025 figure stands as the lowest quarterly Other Operating Expenses since Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Immunome 2.44 Bn 410.39 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 10.00 Mn
Dec 31, 2024 27.37 Mn
Sep 30, 2024 6.71 Mn
Jun 30, 2024 6.31 Mn
Mar 31, 2024 111.95 Mn
Dec 31, 2023 80.80 Mn
Sep 30, 2020 5.56 Mn
Dec 31, 2019 34,000.00
Sep 30, 2019 17,000.00
API Access

Immunome Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=IMNM&period=max&api_key=YOUR_API_KEY